Legend Biotech (NasdaqGS:LEGN): A Fresh Look at Valuation Following This Week's Share Price Rebound [Yahoo! Finance]
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: Yahoo! Finance
Its stock performance reflects a mix of cautious optimism and uncertainty around broader industry trends. See our latest analysis for Legend Biotech. This week's 5.79% pop in Legend Biotech's share price is a welcome shift after months of fading enthusiasm. However, its 1-year total shareholder return remains in negative territory at -26.01%. The stock has shown some short-term momentum but is still working to regain investor confidence for the long haul. If this rebound has you interested in more opportunities, now is the perfect time to widen your scope and discover See the full list for free. With shares down significantly over the past year and recent gains igniting debate, investors are left wondering if Legend Biotech is now attractively undervalued or if the market has already factored in its future prospects. Most Popular Narrative: 56.3% Undervalued Legend Biotech's narrative signals a striking valuation gap, with fair value estimates significantly exceeding the l
Show less
Read more
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- Legend Biotech (NASDAQ:LEGN) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- Legend Biotech (NASDAQ:LEGN) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- William Blair Maintains Hold Rating on Legend Biotech (LEGN) Despite Carvykti Label Safety Concerns [Yahoo! Finance]Yahoo! Finance
- Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps UpPR Newswire
- Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps UpPR Newswire
LEGN
Sec Filings
- 11/17/25 - Form 144
- 11/12/25 - Form 6-K
- 11/5/25 - Form SCHEDULE
- LEGN's page on the SEC website